Zhejiang Dayang Biotech Group Co., Ltd was established in 1976 and transformed to a limited company in 2003. It completed the restructuring of the joint stock limited company in 2009 and has four wholly owned subsidiaries. It is a National High-tech Enterprise, Zhejiang "Contract-honoring and Credit-reliable" Enterprise, and Zhejiang Advanced Clean Production Enterprise. The company was listed on the New OTC (Over the Counter) Market in 2016, with stock abbreviation: Dayang Biotech and stock code: 837112.

The company is mainly engaged in the production and operation of three core industries of potassium salt, veterinary drug and fluorine chemicals and has passed the international system certificate of ISO9001, ISO14001, ISO22000 and OHSAS18001 earlier. With potassium carbonate, potassium bicarbonate and ammonium chloride as the leading products, it forms the product group of food additive grade, industrial grade, agricultural grade, etc.; The Amprolium HCL products with high drug efficiency and coccidial resistance have passed the FDA Certification and Veterinary Drug GMP System Certification, and those series of products with high fluidity, high quality and low impurity have been developed according to different requirements for Amprolium HCL products in the market. The company's all veterinary drug premixes certified by Veterinary Drug GMP System Certification are exported overseas. The fine chemicals containing fluorine mainly includes 2-Chloro-6-fluorobenzaldehyde and other series of varieties. Insisting on the development with the international strategy thinking, the products sell well in dozens of countries and regions around the world.

The company has two provincial institutes of technology and a new post-doctoral research center, with multiple patent technologies and strong R&D ability. It leads the drafting of national technical standards and energy consumption standards for potassium carbonate. It is a National Intellectual Property Advantage Enterprise and Zhejiang Patent Demonstration Enterprise.